Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (688180 CH)
Watchlist
44
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Shanghai Junshi Biosciences
•
24 Mar 2021 09:13
Shanghai Junshi Bioscience - Here Are the Challenges
The article analyzed the concerns and challenges that Junshi has to face in terms of PD-1, COVID-19 antibody drug, other products in the pipeline...
Xinyao (Criss) Wang
Follow
210 Views
Share
bullish
•
Shanghai Junshi Biosciences
•
27 Feb 2021 18:29
STAR Board - STAR50 Index Rebalance: Another BIG One
There are 5 changes to the STAR50 index as a part of the March review. Estimated one-way turnover is 8.93% and we expect the inclusions to...
Brian Freitas
Follow
418 Views
Share
bullish
•
Cambricon Technologies Lt
•
21 Jan 2021 14:19
STAR Board - STAR50 Index Rebalance Preview: +Adds/-Deletes = +24%
There will be 5 changes for the STAR50 index in the March review. The lack of pre-positioning and large AUM tracking the index (plus active traders...
Brian Freitas
Follow
532 Views
Share
bearish
•
Quantitative Analysis
•
17 Sep 2023 10:10
A-H Premium Weekly (Sep 15th): Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec Oilfield
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec...
Ke Yan, CFA, FRM
Follow
448 Views
Share
First
Previous
5
6
7
8
9
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x